CHA
CHA2DS2-VASc
atrial fibrillation
bleeding
percutaneous coronary intervention
thromboembolism
Journal
European journal of clinical investigation
ISSN: 1365-2362
Titre abrégé: Eur J Clin Invest
Pays: England
ID NLM: 0245331
Informations de publication
Date de publication:
Apr 2022
Apr 2022
Historique:
revised:
10
11
2021
received:
15
10
2021
accepted:
13
11
2021
pubmed:
19
11
2021
medline:
18
3
2022
entrez:
18
11
2021
Statut:
ppublish
Résumé
In 2010, the European Society of Cardiology Guidelines on atrial fibrillation (AF) introduced the CHA We included 6,014 patients with AF undergoing first-time PCI in Western Denmark between 2003 and 2017. We divided patients into four groups based on year of PCI and estimated 1-year risks of major adverse cardiac events (MACE) and hospitalization for bleeding. The proportion of oral anticoagulation users was 48% in 2003-2006 and 49% in 2006-2010. Following the CHA Implementation of the CHA
Substances chimiques
Anticoagulants
0
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
e13717Informations de copyright
© 2021 Stichting European Society for Clinical Investigation Journal Foundation. Published by John Wiley & Sons Ltd.
Références
Camm AJ , Kirchhof P , Lip GYH , et al. Guidelines for the management of atrial fibrillation: the task force for the management of atrial fibrillation of the European society of cardiology (ESC). Eur Heart J. 2010;31(19):2369-2429. doi:10.1093/eurheartj/ehq278
Lip GY , Nieuwlaat R , Pisters R , Lane DA , Crijns HJ . Refining clinical risk stratification for predicting stroke and thromboembolism in atrial fibrillation using a novel risk factor-based approach: the euro heart survey on atrial fibrillation. Chest. 2010;137(2):263-272. doi:10.1378/chest.09-1584
Lip G , Huber K , Andreotti F , et al. Management of antithrombotic therapy in atrial fibrillation patients presenting with acute coronary syndrome and/or undergoing percutaneous coronary intervention/ stenting. Thromb Haemost. 2010;103(01):13-28. doi:10.1160/th09-08-0580
Rasmussen K , Maeng M , Kaltoft A , et al. Efficacy and safety of zotarolimus-eluting and sirolimus-eluting coronary stents in routine clinical care (SORT OUT III): a randomised controlled superiority trial. Lancet. 2010;375(9720):1090-1099. doi:10.1016/s0140-6736(10)60208-5
Schmidt M , Maeng M , Madsen M , Sorensen HT , Jensen LO , Jakobsen CJ . The Western Denmark heart registry: its influence on cardiovascular patient care. J Am Coll Cardiol. 2018;71(11):1259-1272. doi:10.1016/j.jacc.2017.10.110
Schmidt M , Pedersen L , Sorensen HT . The Danish civil registration system as a tool in epidemiology. Eur J Epidemiol. 2014;29(8):541-549. doi:10.1007/s10654-014-9930-3
Schmidt M , Schmidt SA , Sandegaard JL , Ehrenstein V , Pedersen L , Sorensen HT . The Danish national patient registry: a review of content, data quality, and research potential. Clin Epidemiol. 2015;7:449-490. doi:10.2147/CLEP.S91125
Pottegard A , Schmidt SAJ , Wallach-Kildemoes H , Sorensen HT , Hallas J , Schmidt M . Data resource profile: the Danish national prescription registry. Int J Epidemiol. 2017;46(3):798-798f. doi:10.1093/ije/dyw213
Grundy SM , Stone NJ , Bailey AL , et al. 2018 AHA/ACC/AACVPR/AAPA/ABC/ACPM/ADA/AGS/APhA/ASPC/NLA/PCNA guideline on the management of blood cholesterol: a report of the American college of cardiology/American heart association task force on clinical practice guidelines. Circulation. 2019;139(25):e1091. doi:10.1161/cir.0000000000000625
Egholm G , Madsen M , Thim T , et al. Evaluation of algorithms for registry-based detection of acute myocardial infarction following percutaneous coronary intervention. Clin Epidemiol. 2016;8:415-423. doi:10.2147/clep.s108906
Krarup L-H , Boysen G , Janjua H , Prescott E , Truelsen T . Validity of stroke diagnoses in a national register of patients. Neuroepidemiology. 2007;28(3):150-154. doi:10.1159/000102143
Sørensen R , Hansen ML , Abildstrom SZ , et al. Risk of bleeding in patients with acute myocardial infarction treated with different combinations of aspirin, clopidogrel, and vitamin K antagonists in Denmark: a retrospective analysis of nationwide registry data. The Lancet. 2009;374(9706):1967-1974. doi:10.1016/s0140-6736(09)61751-7
Zou G . A modified poisson regression approach to prospective studies with binary data. Am J Epidemiol. 2004;159(7):702-706. doi:10.1093/aje/kwh090
Pisters R , Lane DA , Nieuwlaat R , De Vos CB , Crijns HJGM , Lip GYH . A novel user-friendly score (HAS-BLED) to assess 1-year risk of major bleeding in patients with atrial fibrillation. Chest. 2010;138(5):1093-1100. doi:10.1378/chest.10-0134
Kirchhof P , Benussi S , Kotecha D , et al. 2016 ESC guidelines for the management of atrial fibrillation developed in collaboration with EACTS. Eur Heart J. 2016;37(38):2893-2962. doi:10.1093/eurheartj/ehw210
Hindricks G , Potpara T , Dagres N , et al. ESC guidelines for the diagnosis and management of atrial fibrillation developed in collaboration with the European association of cardio-thoracic surgery (EACTS). Eur Heart J. 2020;2020:60-62. doi:10.1093/eurheartj/ehaa612
Cannon CP , Bhatt DL , Oldgren J , et al. Dual antithrombotic therapy with dabigatran after PCI in atrial fibrillation. N Engl J Med. 2017;377(16):1513-1524. doi:10.1056/NEJMoa1708454
Lopes RD , Heizer G , Aronson R , et al. Antithrombotic therapy after acute coronary syndrome or PCI in atrial fibrillation. N Engl J Med. 2019;380(16):1509-1524. doi:10.1056/NEJMoa1817083
Gibson CM , Mehran R , Bode C , et al. Prevention of bleeding in patients with atrial fibrillation undergoing PCI. N Engl J Med. 2016;375(25):2423-2434. doi:10.1056/NEJMoa1611594
Dewilde WJ , Oirbans T , Verheugt FW , et al. Use of clopidogrel with or without aspirin in patients taking oral anticoagulant therapy and undergoing percutaneous coronary intervention: an open-label, randomised, controlled trial. Lancet. 2013;381(9872):1107-1115. doi:10.1016/s0140-6736(12)62177-1
Fiedler KA , Maeng M , Mehilli J , et al. Duration of triple therapy in patients requiring oral anticoagulation after drug-eluting stent implantation: the ISAR-TRIPLE trial. J Am Coll Cardiol. 2015;65(16):1619-1629. doi:10.1016/j.jacc.2015.02.050
Lip GY , Huber K , Andreotti F , et al. Management of antithrombotic therapy in atrial fibrillation patients presenting with acute coronary syndrome and/or undergoing percutaneous coronary intervention/ stenting. Thromb Haemost. 2010;103(1):13-28. doi:10.1160/th09-08-0580
Steg PG , James SK , Atar D , et al. ESC guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation. Eur Heart J. 2012;33(20):2569-2619. doi:10.1093/eurheartj/ehs215
Lip GYH , Huber K , Andreotti F , et al. Antithrombotic management of atrial fibrillation patients presenting with acute coronary syndrome and/or undergoing coronary stenting: executive summary-a consensus document of the European society of cardiology working group on thrombosis, endorsed by t. Eur Heart J. 2010;31(11):1311-1318. doi:10.1093/eurheartj/ehq117
Cannon CP , Braunwald E , McCabe CH , et al. Intensive versus moderate lipid lowering with statins after acute coronary syndromes. N Engl J Med. 2004;350(15):1495-1504. doi:10.1056/nejmoa040583
Pedersen TR . High-dose atorvastatin vs usual-dose simvastatin for secondary prevention after myocardial infarction. The IDEAL study: a randomized controlled trial. JAMA. 2005;294(19):2437. doi:10.1001/jama.294.19.2437
Nissen SE , Nicholls SJ , Sipahi I , et al. Effect of very high-intensity statin therapy on regression of coronary atherosclerosis. JAMA. 2006;295(13):1556. doi:10.1001/jama.295.13.jpc60002
Mortensen MB , Nordestgaard BG . Elevated LDL cholesterol and increased risk of myocardial infarction and atherosclerotic cardiovascular disease in individuals aged 70-100 years: a contemporary primary prevention cohort. Lancet. 2020;396(10263):1644-1652. doi:10.1016/s0140-6736(20)32233-9
Gencer B , Marston NA , Im K , et al. Efficacy and safety of lowering LDL cholesterol in older patients: a systematic review and meta-analysis of randomised controlled trials. Lancet. 2020;396(10263):1637-1643. doi:10.1016/s0140-6736(20)32332-1